StemCells Inc. Provides Additional Comments on Recent Awards From the California Institute for Regenerative Medicine

Published: Sep 10, 2012

NEWARK, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that Martin McGlynn, President and CEO, provided additional comments about the approval of two funding awards by the California Institute for Regenerative Medicine (CIRM).

Back to news